U.S. flag An official website of the United States government
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  1. Safety

Recalls, Market Withdrawals, & Safety Alerts

The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.

The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Email Icon for GovDeliverySign up to receive Recalls, Market Withdrawals and Safety Alerts.
* FDA Employees: Use Chrome to Subscribe until further notice.

A Terminated Recall is a recall where the FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. Recalls that are not indicated as being terminated are either ongoing or completed.

Date Brand Name(s) Product Description Product Type Recall Reason Description Company Name Terminated Recall Excerpt
Arrow Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR Medical Devices Inner lumen may detach from the device’s basket Teleflex Incorporated … of native arterio-venous (AV) fistulae and synthetic dialysis grafts. The products involved in the recall are as …
B. Braun Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container Drugs Out-of-Specification Results for High Molecular Weight Polymers Braun Medical Inc Terminated … key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating …
Baxter intravenous (IV) solutions: 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container and 70% Dextrose Injection (2000 mL) USP Drugs Labeled as Eliquis5 mg was found to contain Eliquis 2.5 mg tablets Baxter International Inc. Terminated … and may also be used as a priming solution in hemodialysis procedures. 70% Dextrose Injection (2000 mL) USP is … and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and …
Back to Top